Sitostanol formulation to reduce cholesterol absorption and meth

Details Sitostanol formulation to reduce cholesterol absorption and meth Sitostanol formulation to reduce cholesterol absorption and meth

1998-05-26

1999-08-03

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

514182, 514824, A61K 31685, A61K 3156

Patent

active

059325623

ABSTRACT:
Compositions useful to reduce cholesterol absorption. The compositions may be dosed in capsule or tablet form, or by adding either in liquid or dry powder form to foods and beverages. The compositions are an aqueous based homogeneous micellar mix which is dried to provide a mixture of finely-divided plant sterol, preferably sitostanol and lecithin. The mole ratio of the plant sterol, preferably sitostanol to lecithin, should be within the range of 1:1 to 1:10, preferably at least 1:2.

REFERENCES:
patent: 5244887 (1993-09-01), Straub

Affiliated with

Also associated with

Rating

Sitostanol formulation to reduce cholesterol absorption and meth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sitostanol formulation to reduce cholesterol absorption and meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sitostanol formulation to reduce cholesterol absorption and meth will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-849592